• Eicosapentaenoic Acid in Cardiovascular Disease Research

  2026-07-10

  Eicosapentaenoic Acid (EPA) stands out as a rigorously validated omega-3 fatty acid for cardiovascular and inflammation studies, enabling reproducible modulation of lipid profiles and cellular responses. This guide translates high-purity EPA use into workflow-ready steps, troubleshooting, and comparative insights, empowering advanced research with APExBIO’s trusted reagent.

• MRT68921: Precision ULK1 Inhibition and Lipid Autophagy Deco

  2026-07-09

  Explore how MRT68921, a cutting-edge ULK1 kinase inhibitor, enables rigorous dissection of lipid autophagy and lipotoxicity. This article uniquely bridges molecular mechanism with advanced lipidomics insights, setting a new standard for autophagy research.

• Sulfo-Cy3 NHS Ester: Enabling Quantitative Protein Labeling

  2026-07-09

  Explore how Sulfo-Cy3 NHS Ester, a hydrophilic fluorescent dye, uniquely advances quantitative protein labeling in vascular biology and collateral circulation research. This article delivers an in-depth technical analysis, bridging new mechanistic insights from recent vascular remodeling studies with advanced labeling protocols.

• AIBP-LRP2–HDL Axis Regulates CXCR4+ Capillary Expansion in I

  2026-07-08

  Zhu et al. uncover a mechanism where AIBP and LRP2 mediate HDL uptake to restrict the expansion of CXCR4+ stemlike capillary endothelial cells, thereby limiting collateral circulation in ischemic tissues. This study provides new therapeutic targets for enhancing revascularization in peripheral artery disease.

• SMYD2 Inhibition Mitigates Cisplatin-Induced Renal Fibrosis

  2026-07-08

  The reference study demonstrates that pharmacological inhibition of SMYD2, including by LLY-507, protects against cisplatin-induced renal fibrosis and inflammation in models of chronic kidney disease. These findings highlight SMYD2 as a promising epigenetic target for antifibrotic interventions and provide a mechanistic basis for developing selective SMYD2 inhibitors in kidney disease research.

• Aztreonam: Applied Protocols for Gram-Negative Resistance Re

  2026-07-07

  Aztreonam stands out as a monocyclic β-lactam antibiotic, uniquely enabling high-precision studies on Gram-negative aerobic bacteria and multidrug resistance mechanisms. This article translates recent reference breakthroughs into actionable workflows, optimizing experimental design for both antibiotic activity and host-drug interaction research.

• Cy7 NHS Ester: Practical Guide for Near-Infrared Protein Lab

  2026-07-07

  Cy7 NHS ester addresses the challenge of water-soluble, high-sensitivity labeling of proteins and peptides for near-infrared fluorescent imaging, especially in workflows requiring minimal protein denaturation and robust optical signals. It is best suited for applications involving accessible amino groups and immediate reagent use; it is not recommended for targets without primary amines or protocols needing long-term dye solution storage.

• EZ Cap™ Cre mRNA (m1Ψ): Precision mRNA for Efficient Gene Ed

  2026-07-06

  EZ Cap™ Cre mRNA (m1Ψ) is a stabilized, low-immunogenicity Cre recombinase mRNA ideal for gene editing and functional studies. The Cap 1 and m1Ψ modifications ensure high translation efficiency and mRNA lifetime, supporting reproducible results across in vitro and in vivo workflows.

• Necrostatin 2 (Nec-2): Pioneering Necroptosis Inhibition in

  2026-07-06

  This thought-leadership article offers a mechanistic and strategic exploration of Necrostatin 2 (Nec-2) as a next-generation necroptosis inhibitor. Translational researchers gain an integrated view of RIPK2 targeting, protocol best practices, and future prospects, while drawing connections to emerging cell death mechanisms and the tumor immune landscape.

• Chlorin e6 in Photodynamic Therapy: Mechanistic Insights & I

  2026-07-05

  Explore Chlorin e6 as a leading Ce6 photosensitizer for advanced photodynamic therapy. This article uniquely unpacks emerging mechanisms such as pyroptosis and immunogenic cell death, empowering researchers with deeper scientific context and protocol guidance.

• Cy7 NHS Ester: Practical Guidance for Near-Infrared Labeling

  2026-07-04

  Cy7 NHS ester is a sulfonated, highly water-soluble near-infrared dye optimized for labeling amino groups on proteins and peptides, supporting sensitive in vitro and in vivo imaging. It is best applied where high labeling efficiency and low protein denaturation risk are required and is not recommended for workflows needing long-term solution storage or extreme photostability.

• Danazol in Endocrine Research: Applied Protocols & Innovatio

  2026-07-03

  Danazol is a cornerstone tool for modeling steroidogenesis inhibition and HPG axis modulation in translational endocrinology. This article unpacks actionable protocols, troubleshooting strategies, and new insights from recent animal model research for maximizing Danazol’s relevance in both mechanistic and applied investigations.

• Cy7 NHS Ester: Technical Guidance for Near-Infrared Protein

  2026-07-03

  Cy7 NHS ester provides a sulfonated, hydrophilic near-infrared dye for bioimaging, specifically enabling efficient and gentle labeling of proteins and peptides via amino groups. It is best suited for workflows requiring high water solubility and minimal quenching for in vivo or in vitro imaging but is not recommended for long-term solution storage or for non-amine labeling applications.

• Sulfo-NHS-SS-Biotin: Disulfide Biotinylation for Dynamic Pro

  2026-07-02

  Explore Sulfo-NHS-SS-Biotin as a cutting-edge biotin disulfide N-hydroxysulfosuccinimide ester for reversible protein labeling, enabling advanced studies in protein maturation, surface proteomics, and affinity purification. This article uniquely connects reversible biotinylation strategies to post-translational modification research, highlighting practical considerations and latest scientific findings.

• Sulfo-Cy7 NHS Ester: Technical Guide for Protein Labeling

  2026-07-02

  Cy7 NHS ester addresses challenges in labeling biomolecules for near-infrared imaging by combining high water solubility with minimized fluorescence quenching. It is optimal for protocols where organic co-solvents threaten protein integrity, but its use is limited to amino group labeling and short-term solution stability.

510 records 9/34 page Previous Next First page 上5页 678910 下5页 Last page